Medical expulsive therapy of ureteral calculi and supportive therapy after extracorporeal shock wave lithotripsy

European Urology, Supplements

Volumn 9, Issue 12, 2010, Pages 807-813

  Seitz, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Expulsive therapy; Medical treatment; Shock wave lithotripsy; Urolithiasis

Indexed keywords

5 METHYLURAPIDIL; ALFUZOSIN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEFLAZACORT; DICLOFENAC; DIPYRONE; DIURETIC AGENT; DOXAZOSIN; IBUPROFEN; INDOMETACIN; NAFTOPIDIL; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PAPAVERINE; PETHIDINE; PLACEBO; ROWATINEX; SCOPOLAMINE; SCOPOLAMINE BUTYL BROMIDE; TAMSULOSIN; TERAZOSIN; TERPENE; UNCLASSIFIED DRUG; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ANALGESIC ACTIVITY; ARTICLE; COLIC PAIN; COMPETITIVE INHIBITION; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EXTRACORPOREAL LITHOTRIPSY; FLUID INTAKE; GERMANY; HOSPITAL ADMISSION; HUMAN; KIDNEY PAIN; MEDICAL EXPULSIVE THERAPY; MEDICAL LITERATURE; PATHOPHYSIOLOGY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; THERAPY; UNSPECIFIED SIDE EFFECT; URETER STONE; UROLITHIASIS;

EID: 78650718949     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2010.11.008     Document Type: Article

References (68)

1. Hübner W.A., Irby P., Stoller M.L. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993, 24:172-176.
2. Miller O.F., Kane C.J. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999, 162:688-690. discussion 690-1.
3. Dal Moro F., Abate A., Lanckriet G.R., et al. A novel approach for accurate prediction of spontaneous passage of ureteral stones: support vector machines. Kidney Int 2006, 69:157-160.
4. Preminger G.M., Tiselius H.-G., Assimos D.G., et al. European Association of Urology. 2007 guideline for the management of ureteral calculi. Eur Urol 2007, 52:1610-1631. American Urological Association Education and Research, Inc.
5. Hertle L., Nawrath H. Calcium channel blockade in smooth muscle of the upper urinary tract I: effects on depolarization-induced activation. J Urol 1984, 132:1265-1269.
6. Borghi L., Meschi T., Amato F., et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 1994, 152:1095-1098.
7. Sahin A., Erdemli I., Bakkaloglu M., Ergen A., Basar I., Remzi D. The effect of nifedipine and verapamil on rhythmic contractions of human isolated ureter. Arch Int Physiol Biochim Biophys 1993, 101:245-247.
8. Hieble J.P., Bylund D.B., Clarke D.E., et al. International Union of Pharmacology. X. Recommendations for nomenclature of alpha1-adrenoceptors: Consensus update. Pharmacol Rev 1995, 47:267-270.
9. 1 adrenoceptor subtypes in the human ureter. Neurourol Urodynam 2005, 24:142-148.
10. Itoh Y., Kojima Y., Yasui T., Tozawa K., Sasaki S., Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 2007, 14:749-753.
11. Uberti M.A., Hall R.A., Minneman K.P. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 2003, 64:1379-1390.
12. Ahmad M., Chaughtai M.N., Kahn F.A. Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. J Pak Med Assoc 1991, 41:268-270.
13. Holmlund D., Hassler O. A method of studying the ureteral reaction to artificial concrements. Acta Chir Scand 1965, 130:335-343.
14. Yamaguchi K., Minei S., Yamazachi T., Kaya H., Okada K. Characterization of ureteral lesions associated with impacted stones. Int J Urol 1999, 6:281-285.
15. Worster A., Richards C. Fluids and diuretics for acute ureteric colic. Cochrane Database Syst Rev 2005, CD004926.
16. Tiselius H.G., Aronsen T., Bohgard S., et al. Is high diuresis an important prerequisite for successful SWL-disintegration of ureteral stones?. Urol Res 2010, 38:143-146.
17. Mastrangelo D., Wisard M., Rohner S., Leisinger H., Iselin C.E. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist induced contractions of the pig isolated ureter. Urol Res 2000, 28:376-382.
18. Jerde T.J., Calamon-Dixon J.L., Bjorling D.E., Nakada S.Y. Celecoxib inhibits ureteral contractility and prostanoid release. Urology 2005, 65:185-190.
19. Laerum E., Ommundsen O.E., Grønseth J.E., Christiansen A., Fagertun H.E. Oral diclofenac in the prophylactic treatment of recurrent renal colic. A double-blind comparison with placebo. Eur Urol 1995, 28:108-111.
20. Phillips E., Hinck B., Pedro R., et al. Celecoxib in the management of acute renal colic: a randomized controlled clinical trial. Urology 2009, 74:994-999.
21. Lee C.B., Ha U.S., Lee S.J., Kim S.W., Cho Y.H. Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol 2006, 24:55-60.
22. Djaladat H., Mahouri K., Khalifeh Shooshtary F., Ahmadieh A. Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy. Urol J 2009, 6:9-13.
23. Zwergel U., Felgner J., Rombach H., Zwergel T.H. Aktuelle konservative Behandlung einer Nierenkolik: Stellenwert der Prostaglandinsynthesehemmer. Der Schmerz 1998, 12:112-117.
24. Holmlund D., Sjödin J.G. Treatment of ureteral colic with indomethacin. J Urol 1978, 120:676-677.
25. Schneider T., Fetscher C., Krege S., Michel M.C. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 2004, 309:1148-1153.
26. Holdgate A., Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 2004, 328(7453):1401-1404.
27. Edwards J.E., Meseguer F., Faura C., Moore R.A., McQuay H.J. Single dose dipyrone for acute renal colic pain. Cochrane Database Syst Rev 2002, CD003867.
28. Kühn R., Ückert S., Stief C.G., et al. Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res 2000, 28:110-115.
29. Gratzke C., Ückert S., Reich O., et al. PDE-5-Inhibitoren: Ein neuer Therapieansatz in der Behandlung der Harnleiterkolik?. Der Urologe 2007, 46:1219-1223.
30. Snir N., Moskovitz B., Nativ O., et al. Papaverine hydrochloride for the treatment of renal colic: an old drug revisited-a prospective randomized study. J Urol 2008, 179:1411-1414.
31. Yencilek F., Aktas C., Goktas C., Yilmaz C., Yilmaz U., Sarica K. Role of papaverine hydrochloride administration in patients with intractable renal colic: randomized prospective trial. Urology 2008, 72:987-990.
32. Mikkelsen A.L., Meyhoff H.H., Lindahl F., Christensen J. The effect of hydroxyprogesterone on ureteral stones. Int Urol Nephrol 1988, 20:257-260.
33. Salehi M., Fouladi Mehr M., Shiery H., et al. Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stones?. Eur Urol Suppl 2005, 4(3):25.
34. Davenport K., Timoney A., Keeley F.X. Effect on smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res 2007, 35:207-213.
35. Davenport K., Timoney A., Keeley F.X. A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha (1)-adrenoceptor antagonism on human ureteric activity. BJU Int 2006, 98:651-655.
36. Seitz C., Liatsikos E., Porpiglia F., Tiselius H.-G., Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence?. Eur Urol 2009, 56:455-471.
37. 1-adrenergic blockers for distal ureteral stones. J Urol 2005, 173:2010-2012.
38. Ukhal M.I., Malomuzh O.I., Strashny V. Administration of doxazosin for speedy elimination of stones from lower section of ureter. Eur Urol 1999, 35(Suppl):4-6.
39. Mohseni M.G., Hosseini S.R., Alizadeh F. Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi Med J 2006, 27:838-840.
40. Ayubov B., Arustamov D., Mukhtarov S. Efficacy of doxazosin in the management of ureteral stones. Eur Urol Suppl 2007, 6:114.
41. Liatsikos E.N., Katsakiori P.F., Assimakopoulos K., et al. Doxazosin for the management of distal-ureteral stones. J Endourol 2007, 21:538-541.
42. Mukhtarov S., Turdiev A., Fozilov A., et al. Using doxazosin for distal ureteral stone clearance with or without shock wave lithotripsy. Eur Urol Suppl 2007, 6:216.
43. Sun X., He L., Ge W., Lv J. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 2009, 181:1716-1720.
44. Pedro R.N., Hinck B., Hendlin K., Feia K., Canales B.K., Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 2008, 179:2244-2247. discussion 2247.
45. Vincendeau S., Bellissant E., Bansalah K., et al. Lack of efficacy of tamsulosin in the treatment of distal ureteral stones. Eur Urol Suppl 2008, 7:149.
46. Hermanns T., Sauermann P., Rufibach K., Frauenfelder T., Sulser T., Strebel R.T. Is there a role for tamsulosin in the treatment of distal ureteral stones of 7mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 2009, 56:407-412.
47. Ferre R.M., Wasielewski J.N., Strout T.D., Perron A.D. Tamsulosin for ureteral stones in the emergency department: a randomized controlled trial. Ann Emerg Med 2009, 54:432-439.
48. Keshvary M., Taghavi R., Arab D. The effect of tamsulosin and nifedipine in facilitating juxtavesical stones' passage. Med J Mashhad University Med Sci 2006, 48:425-430.
49. Porpiglia F., Ghignone G., Fiori C., Fontana D., Scarpa R.M. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004, 172:568-571.
50. Dellabella M., Milanese G., Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005, 174:167-172.
51. Gravas S., Tzortzis V., Karatzas A., Oeconomou A., Melekos M.D. The use of tamsulosin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 2007, 35:231-235.
52. Gravina G.L., Costa A.M., Ronchi P. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005, 66:24-28.
53. Han M.C., Park Y.Y., Shim B.S. Effect of tamsulosin on the expectant treatment of lower ureteral stones. Korean J Urol 2006, 47:708-711.
54. Resim S., Ekerbicer H.C., Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005, 66:945-948.
55. Shaaban Alaa M., Barsoum Nady M., Sagheer Gamal A., Ahmed Z. Is there a role for alpha blocker after SWL for renal and upper ureteral stones?. J Urol 2008, 179:A1459.
56. Kobayashi M., Naya Y., Kino M. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 2008, 15:495-498.
57. Bhagat S.K., Chacko N.K., Kekre N.S., Gopalakrishnan G., Antonisamy B., Devasia A. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?. J Urol 2007, 177:2185-2188.
58. Naja V., Agarwal M.M., Mandal A.K., et al. Tamsulosin facilitates earlier clearance of stone fragments and reduces pain after shockwave lithotripsy for renal calculi: results from an open-label randomized study. Urology 2008, 72:1006-1011.
59. Hussein M.M. Does tamsulosin increase stone clearance after shockwave lithotripsy of renal stones? A prospective, randomized controlled study. Scand J Urol Nephrol 2010, 44:27-31.
60. ®): results of a placebo-controlled, randomized trial. Eur Urol Suppl. 2010, 9:819-825.
61. Han M.C., Jeong W.S., Shim B.S. Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol 2006, 47:813-817.
62. Porpiglia F., Destefanis P., Fiori C., Scarpa R.M., Fontana D. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 2002, 59:835-838.
63. Agarwal M.M., Naja V., Singh S.K., et al. Is there an adjunctive role of tamsulosin to extracorporeal shockwave lithotripsy for upper ureteric stones: results of an open label randomized nonplacebo controlled study. Urology 2009, 74:989-992.
64. Küpeli B., Irkilata L., Gürocak S., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 2004, 64:1111-1115.
65. Porpiglia F., Destefanis P., Fiori C., Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000, 56:579-582.
66. Bensalah K., Pearle M., Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 2008, 53:411-419.
67. Hollingsworth J.M., Rogers M.A., Kaufman S.R., et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006, 368:1171-1179.
68. Lotan Y., Cadeddu J.A., Paerle M.S. International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res 2005, 33:223-230.